ALEC:NASDAQ, Alector, Inc.

ALEC stock overview

Alector, Inc. (ALEC:NASDAQ) closed at $2.56 on November 17, 2026, down 0.39% on the day. The stock trades 9.9% below its 52-week high of $2.84 and 134.9% above its 52-week low of $1.09. Over the past year, it gained 101.6%. Alector, Inc. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).

Key figures

Price
$2.56
Day change
-0.39%
Volume
1,268,916
Average volume
3,386,492
Market cap
381M+
52-week range
$1.09 – $2.84
50-day average
$2.07
200-day average
$2.06

Price action over the past year

In 252 trading sessions since November 17, 2025, ALEC closed higher on 119 days (47%). Its best day was August 11, 2026 (+23.67%) and its worst was May 8, 2026 (-13.93%). The stock moved 10% or more in a single session 12 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

ALEC news

About Alector, Inc.

Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain.

Similar stocks

Find more stocks like ALEC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.